Veterinary Biologics Market: Is 2026 the Year mRNA Vaccines and...

toegevoegd een audio Health

2026-02-16 07:11:52 -

Veterinary Biologics Market: Is 2026 the Year mRNA Vaccines and "Pet-Specific" Monoclonals Replace Traditional Medicine?

In early 2026, the Veterinary Biologics Market is valued at approximately $14.8 billion, witnessing a radical shift toward "Precision Immunology." This year, the industry is buzzing over the transition to mRNA and DNA-based veterinary vaccines, which allow for rapid "strain-matching" against emerging outbreaks like Avian Influenza and Foot-and-Mouth Disease. This innovation is a primary driver...

0 Reacties 0 aandelen 189 Views 0 voorbeeld